Innoviva, Inc. (INVA)
24.03
+0.61
(+2.60%)
USD |
NASDAQ |
Feb 25, 12:32
Innoviva Price : 24.03 for Feb. 25, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Merck & Co., Inc. | 122.78 |
| Nektar Therapeutics | 70.36 |
| Regeneron Pharmaceuticals, Inc. | 789.88 |
| Oramed Pharmaceuticals, Inc. | 3.555 |
| Theravance Biopharma, Inc. | 19.31 |
Price Related Metrics
| PE Ratio | 17.24 |
| PS Ratio | 4.723 |
| PEG Ratio | 0.1680 |
| Price to Book Value | 1.779 |
| Price to Free Cash Flow | 9.669 |
| Earnings Yield | 5.80% |
| Market Cap | 1.797B |
| PEGY Ratio | 0.1680 |
| Operating PE Ratio | 11.32 |
| Normalized PE Ratio | 13.95 |